New late-stage study data shows that treatment with Amgen's Uplizna for a year improves disease symptoms in patients with ...

MariTide’s opportunity in diabetes should not be ignored. In addition to reducing weight by 17%, it reduced HbA1c up to 2.2% ...

Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Amgen's whale ...

Tezspire targets the airway epithelium, the primary source of inflammation. Credit: Emily Frost / Shutterstock. Amgen and AstraZeneca have reported complete outcomes from the registrational Phase III ...

Amgen discovers, develops, manufactures and delivers innovative medicines to help millions of patients in their fight against some of the world's toughest diseases. More than 40 years ago, Amgen ...

Amgen announces the launch of Amgen India, a new technology and innovation hub in Hyderabad, that spans approximately 524,000 ...

THOUSAND OAKS, Calif., Feb. 28, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the 45 th Annual TD Cowen Health Care Conference at 9:10 a.m. ET on Wednesday, March 5, 2025. Jay Bradner, ...

Shares of Apple and Amgen are seeing declines Wednesday afternoon, sending the Dow Jones Industrial Average into negative territory. Supported by world-class markets data from Dow Jones and ...

Dragged down by losses for shares of Boeing and Amgen, the Dow Jones Industrial Average is trading down Wednesday afternoon. Supported by world-class markets data from Dow Jones and FactSet ...

In early February, Amgen released financial results for the 4th quarter of 2024, which I was eagerly awaiting. In addition to demonstrating efficacy in the treatment of nasal polyps in Phase 3 ...

The FDA has approved AstraZeneca and Amgen's severe asthma hope tezepelumab, exonerating the drugmakers' decision to press ahead with a regulatory filing despite a failed phase 3 trial.